This HTML5 document contains 39 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n9http://linked.opendata.cz/resource/drugbank/drug/DB03754/identifier/drugbank/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n13http://bio2rdf.org/drugbank:
n11http://linked.opendata.cz/resource/drugbank/drug/DB03754/identifier/chebi/
admshttp://www.w3.org/ns/adms#
n7http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n10http://linked.opendata.cz/resource/drugbank/drug/DB03754/identifier/pdb/
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
n12http://linked.opendata.cz/resource/drugbank/drug/DB03754/identifier/pubchem-compound/
xsdhhttp://www.w3.org/2001/XMLSchema#
n14http://linked.opendata.cz/resource/drugbank/drug/DB03754/identifier/pubchem-substance/

Statements

Subject Item
n2:DB03754
rdf:type
n3:Drug
n3:description
An organic amine proton acceptor. It is used in the synthesis of surface-active agents and pharmaceuticals; as an emulsifying agent for cosmetic creams and lotions, mineral oil and paraffin wax emulsions, as a biological buffer, and used as an alkalizer. (From Merck, 11th ed; Martindale, The Extra Pharmacopoeia, 30th ed, p1424)
n3:group
experimental
owl:sameAs
n7:DB03754 n13:DB03754
dcterms:title
Tris(Hydroxymethyl)Aminomethane
adms:identifier
n9:DB03754 n10:TMN n11:9754 n12:3777159 n14:46506027
n3:synthesisReference
Jean Bourguignon, Marcel-Xavier Sion, Michel Moreau, "Preparation of tris(hydroxymethyl)aminomethane." U.S. Patent US4233245, issued August, 1959.
n3:IUPAC-Name
n4:271B3F34-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B3F3A-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B3F39-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B3F36-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B3F37-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B3F38-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B3F32-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B3F30-363D-11E5-9242-09173F13E4C5 n4:271B3F33-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B3F31-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B3F40-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B3F41-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B3F3B-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B3F3C-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B3F3E-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B3F3D-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B3F3F-363D-11E5-9242-09173F13E4C5
n3:category
n3:Bioavailability
n4:271B3F46-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B3F48-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B3F49-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B3F45-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B3F44-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B3F47-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B3F35-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B3F42-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B3F43-363D-11E5-9242-09173F13E4C5